-
Product Insights
Rosacea – Drugs In Development, 2023
Global Markets Direct’s, ‘Rosacea - Drugs In Development, 2023’, provides an overview of the Rosacea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rosacea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Radiodermatitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Radiodermatitis - Drugs In Development, 2023’, provides an overview of the Radiodermatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Radiodermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2023
Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drugs In Development, 2023’, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Jnk Inhibitors in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Jnk Inhibitors in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Jnk Inhibitors in Solid Tumor Drug Details: The drug candidate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PCSMD-05 in Radiodermatitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PCSMD-05 in RadiodermatitisDrug Details:PCS-MD05 is under development for the treatment of radiodermatitis. It is a recombinant...
-
Product Insights
Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Pacemakers Pipeline Market Report Overview A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. It can be a single chamber or dual chamber type. The pacemakers pipeline market research report provides comprehensive information about the pacemakers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·      Dual-Chamber...
-
Product Insights
Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Rhythm Management Devices Pipeline Market Report Overview Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD). These devices are used for the treatment of congestive heart failure. The Cardiac Rhythm Management Devices pipeline market research report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the...
-
Product Insights
Radiodermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Radiodermatitis is an inflammation of the skin caused by radiation. The Radiodermatitis pipeline market research report provides comprehensive information on the therapeutics under development for Radiodermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PCSMD-05
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PCSMD-05 Drug Details PCS-MD05 is under development for the treatment of radiodermatitis. It is...